Home›Search›Translational Oncology

Translational Oncology

Neoplasia Press, Inc. · United States · Est. 1955

ISSN1944-7124eISSN1936-5233

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total75

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.408

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.055

Total Works

3,081

Total Citations

66,818

2yr Mean Citedness

3.73

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

Translational Oncology focuses on the molecular mechanisms and therapeutic strategies for various cancers, including hepatocellular carcinoma, ovarian cancer, gastrointestinal stromal tumors, head and neck cancers, pancreatic cancer, breast cancer, colorectal cancer, prostate cancer, and gastric cancer. The journal investigates genetic mutations, epigenetic regulation, long non-coding RNAs, and signaling pathways (e.g., Wnt/β-catenin, Ras, NOTCH) as potential therapeutic targets. It also explores the role of the tumor microenvironment, immune cells, and the gut microbiome in cancer progression and treatment response, as well as the application of novel technologies like nanotechnology, 3D/4D printing, and advanced sequencing methods in cancer research and clinical practice.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1955

Annual Volume~ 338 articles / year

StatusActive (last: 2026)

Total Publications3,081

Publisher OrgElsevier BV

OA Since2007

Visit Journal Website

Submission Info

Peer ReviewPeer review

Review Time~18 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Neoplasia Press, Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1944-7124 / 1936-5233

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ1

Cancer ResearchQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisCancer Cells and MetastasisCancer-related molecular mechanisms researchCancer, Hypoxia, and MetabolismRNA modifications and cancerMicroRNA in disease regulationCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsImmunotherapy and Immune Responses